Related Experiment Video
Updated: Jun 29, 2026

Rapid Analysis of Chromosome Aberrations in Mouse B Lymphocytes by PNA-FISH
Published on: August 19, 2014
Chromosomal instability syndromes are sensitive to poly ADP-ribose polymerase inhibitors
Terry J Gaymes1, Sydney Shall, Farzin Farzaneh
1Department of Haematological Medicine, Leukaemia Sciences Laboratories, The Rayne Institute, Kings College London, Denmark Hill Campus, London, UK.
Abstract:
Poly ADP-ribose polymerase inhibitors have been shown to target cells with homologous recombination DNA repair defects. We report that poly ADP-ribose polymerase inhibitors induces apoptosis in cells deficient in other key DNA repair components. Chromosomal instability disorders, Fanconi Anemia and Bloom's syndrome have dysfunctional DNA repair and an increased likelihood of leukemic transformation. PI addition to Fanconi Anemia and Bloom's syndrome cells resulted in significant apoptosis. Furthermore, poly ADP-ribose polymerase inhibitors induced apoptosis in DNA repair signaling defective ATM(-/-) and NBS(-/-) fibroblasts. Immunocytochemistry showed homologous recombination was abrogated in NBS(-/-) and ATM(-/-) fibroblasts, compromised in Fanconi anemia and normal in Bloom's syndrome cells in response to poly ADP-ribose polymerase inhibitors. Strikingly, poly ADP-ribose polymerase inhibitors increases non-homologous end joining repair activity, whilst non-homologous end joining deficient cells are extremely sensitive to poly ADP-ribose polymerase inhibitors. These data suggest poly ADP-ribose polymerase inhibitors target cells with DNA repair and signaling defects rather than solely defects in homologous recombination improving the potential of poly ADP-ribose polymerase inhibitors therapy in a wider range of cancers.
Insights
Poly ADP-ribose polymerase (PARP) inhibitors induce cancer cell death by targeting DNA repair defects. This study shows PARP inhibitors are effective against cells with various DNA repair deficiencies, expanding their therapeutic potential.
Area of Science:
- Molecular Biology
- Cancer Biology
- Genetics
Background:
- Poly ADP-ribose polymerase (PARP) inhibitors are known to target cancer cells with homologous recombination DNA repair defects.
- Chromosomal instability disorders like Fanconi Anemia and Bloom's syndrome exhibit DNA repair dysfunction and are prone to leukemic transformation.
Purpose of the Study:
- To investigate the efficacy of PARP inhibitors in cells with DNA repair defects beyond homologous recombination.
- To explore the impact of PARP inhibitors on DNA repair pathways, including non-homologous end joining.
Main Methods:
- Treatment of Fanconi Anemia, Bloom's syndrome cells, and ATM(-/-)/NBS(-/-) fibroblasts with PARP inhibitors.
- Assessment of apoptosis induction via cell viability assays.
- Immunocytochemistry to evaluate homologous recombination and non-homologous end joining activity.
Main Results:
- PARP inhibitors induced significant apoptosis in Fanconi Anemia, Bloom's syndrome cells, and ATM(-/-)/NBS(-/-) fibroblasts.
- Homologous recombination was abrogated or compromised in NBS(-/-), ATM(-/-), and Fanconi anemia cells, but normal in Bloom's syndrome cells upon PARP inhibition.
- PARP inhibitors increased non-homologous end joining activity, and cells deficient in this pathway showed extreme sensitivity.
Conclusions:
- PARP inhibitors demonstrate efficacy against a broader range of DNA repair and signaling defects, not limited to homologous recombination.
- These findings suggest an expanded therapeutic window for PARP inhibitors in various cancer types with distinct DNA repair deficiencies.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair
Spontaneous and Induced Mutations

